Vivaldi Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Vivaldi Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,503	Closed	-$123K	–	292
2021 Q3	$123K	Buy	12,503 +3	+0%	+$29	0.03%	282
2021 Q2	$122K	Hold	12,500	–	–	0.02%	288
2021 Q1	$125K	Buy	+12,500	New	+$128K	0.02%	312

Other funds holding FLAC

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

GCM

Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

Vivaldi Capital Management's FLAC Position: Q4 2021 in Review

Vivaldi Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2021, closing a stake of 12,503 shares — an estimated $123K sold.

Vivaldi Capital Management first reported a position in FLAC in Q1 2021 and held it in 3 quarters. The position peaked at $125K in Q1 2021. 48 funds tracked by Wall St. Rank hold FLAC as of Q4 2021.

Vivaldi Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2021 after selling out during the quarter.
Vivaldi Capital Management sold 12,503 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2021, an estimated $123K.
Vivaldi Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 3 quarters.
Vivaldi Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $125K in Q1 2021.
48 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2021.

Based on Vivaldi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.